skip to main | skip to sidebar

Lung Diseases

Asthma,Tuberculosis,Cystic Fibrosis, Non-Small Cell Lung Cancer,Respiratory Tract, Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Status Asthmaticus,Respiratory Syncytial Virus(RSV), Portable Oxygen Concentrator, Home Liquid Oxygen, Emphysema, Pulmonary Arterial Hypertension (PAH)...

Lung Diseases Cies Search Engine [selected websites]

Blog Archive

► 2024 (6)
- ► April (1)
- ► February (2)
- ► January (3)

► 2023 (2)
- ► December (1)
- ► November (1)

▼ 2012 (14)
- ► November (1)
- ► May (1)
- ► April (2)
- ► March (2)
- ► February (2)
- ▼ January (6)

► 2011 (35)
- ► December (1)
- ► November (3)
- ► October (4)
- ► September (4)
- ► August (4)
- ► July (4)
- ► June (5)
- ► May (2)
- ► April (3)
- ► March (5)

► 2010 (63)
- ► December (2)
- ► November (4)
- ► October (4)
- ► September (5)
- ► July (6)
- ► June (13)
- ► May (9)
- ► April (18)
- ► March (1)
- ► January (1)

► 2009 (26)
- ► December (4)
- ► November (10)
- ► July (10)
- ► June (2)

► 2008 (297)
- ► October (25)
- ► September (17)
- ► August (8)
- ► July (29)
- ► June (39)
- ► May (42)
- ► April (50)
- ► March (46)
- ► February (25)
- ► January (16)

► 2007 (90)
- ► December (6)
- ► November (14)
- ► October (27)
- ► September (43)

Jan 16, 2012

GSK: Professor Rob Horne discusses the MyAsthma programme

Publié par Benjamin de Bélizal à l'adresse 5:39 AM

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Libellés : Asthma, GSK

Newer Post Older Post Home

Link

Lung Diseases Cies Search Engine by PharmaPosition

Keywords

TAG : LUNG CANCER
TAG : ASTHMA
TAG : COPD Chronic Obstructive Pulmonary Disease
TAG : CYSTIC FIBROSIS
TAG : Pulmonary Arterial Hypertension (PAH)

My Blog List

French Biotechs

Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada)
9 months ago
Sleep Disorders

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
9 months ago
Diabetes

Recruitment milestone reached in Diamyd® Phase 3 trial
9 months ago
Obesity

CinFina Pharma Announces FDA Clearance of Investigational New Drug Application and First Participants Dosed in Phase 1 Trial of CIN-110 for the Treatment of Obesity
9 months ago
Heart Diseases

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
9 months ago
Alzheimer

AltPep Study Published in Nature Journal, Scientific Reports, Further Affirms Potential of Blood Test to Detect Alzheimer's Disease
9 months ago

Show 5 Show All

Index